277 related articles for article (PubMed ID: 33410494)
21. Secondary immune thrombocytopenia with elevated serum ferritin in a patient with anti-MDA5 antibody-positive dermatomyositis.
Oto Y; Shimoyama T; Ukichi T; Yoshida K; Kurosaka D
Rheumatology (Oxford); 2022 Feb; 61(2):e40-e42. PubMed ID: 34586395
[No Abstract] [Full Text] [Related]
22. Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease disguising as anti-synthetase syndrome.
Tanaka N; Terao C; Nakayama Y; Sasai T; Umezawa N; Yagyu Y; Ito K; Koike R; Nakashima R; Hatta K; Mizoguchi F
Rheumatology (Oxford); 2021 Mar; 60(3):e104-e106. PubMed ID: 33097938
[No Abstract] [Full Text] [Related]
23. Inverse Gottron's Sign in A Patient With Anti-MDA5 Associated Dermatomyositis With Rapidly Progressive Interstitial Lung Disease.
Lee HJ; Feng A; Huan NC
Am J Med Sci; 2021 Oct; 362(4):e35. PubMed ID: 33582154
[No Abstract] [Full Text] [Related]
24. A case of anti-MDA5 antibody-positive dermatomyositis developing reversible cerebral vasospasm syndrome successfully treated by multi-immunosuppressant combination including mycophenolate mofetil.
Muramatsu T; Tono T; Kanayama Y; Hasegawa Y; Kondo J; Hoshiyama T; Wada T; Arinuma Y; Tanaka S; Yamaoka K
Mod Rheumatol Case Rep; 2021 Jan; 5(1):69-75. PubMed ID: 32811369
[TBL] [Abstract][Full Text] [Related]
25. Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum.
Yashiro M; Asano T; Sato S; Kobayashi H; Watanabe H; Miyata M; Migita K
Fukushima J Med Sci; 2018; 64(2):89-94. PubMed ID: 30158335
[TBL] [Abstract][Full Text] [Related]
26. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.
Sakamoto S; Okamoto M; Kaieda S; Fujimoto K; Nagata S; Tominaga M; Nakamura M; Zaizen Y; Nouno T; Koga T; Kawayama T; Kuwana M; Ida H; Hoshino T
Respir Investig; 2018 Nov; 56(6):464-472. PubMed ID: 30150008
[TBL] [Abstract][Full Text] [Related]
27. Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review.
González-Moreno J; Raya-Cruz M; Losada-Lopez I; Cacheda AP; Oliver C; Colom B
Rheumatol Int; 2018 Jul; 38(7):1293-1296. PubMed ID: 29417209
[TBL] [Abstract][Full Text] [Related]
28. Anti-MDA-5-positive dermatomyositis associated rapidly progressive interstitial lung disease, a virus-triggered autoimmune-like symptom?
Xu L; Wang L; Lv C; Tan W
Rheumatology (Oxford); 2021 Sep; 60(9):4428-4429. PubMed ID: 33752230
[No Abstract] [Full Text] [Related]
29. Anti-MDA5 antibody-associated clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease.
Horino T; Inotani S; Nakajima K; Ohnishi H; Komori M; Terada Y
Joint Bone Spine; 2022 Nov; 89(6):105456. PubMed ID: 36108903
[No Abstract] [Full Text] [Related]
30. Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis.
Sakamoto N; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kitazaki T; Kakugawa T; Ishimatsu Y; Satoh M; Mukae H
Intern Med; 2019 Mar; 58(6):837-841. PubMed ID: 30449789
[TBL] [Abstract][Full Text] [Related]
31. Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report.
De Backer E; Gremonprez F; Brusselle G; Depuydt P; Van Dorpe J; Van Haverbeke C; Goeminne PC; Derom E
Acta Clin Belg; 2018 Dec; 73(6):413-417. PubMed ID: 29287518
[TBL] [Abstract][Full Text] [Related]
32. Successful Treatment for Refractory Interstitial Lung Disease and Pneumomediastinum With Multidisciplinary Therapy Including Tofacitinib in a Patient With Anti-MDA5 Antibody-Positive Dermatomyositis.
Kato M; Ikeda K; Kageyama T; Kasuya T; Kumagai T; Furuya H; Furuta S; Tamachi T; Suto A; Suzuki K; Nakajima H
J Clin Rheumatol; 2021 Dec; 27(8S):S574-S577. PubMed ID: 30614890
[No Abstract] [Full Text] [Related]
33. Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies.
Hayashi M; Kikuchi T; Takada T
Clin Rheumatol; 2017 Jan; 36(1):239-240. PubMed ID: 27718019
[No Abstract] [Full Text] [Related]
34. Detection of anti-CADM-140/MDA5 antibodies in a patient with classic dermatomyositis developing rapidly progressive interstitial lung disease.
Miyake M; Sakai A; Nishijima C; Kita T; Nitta E; Kawashima A; Hamaguchi Y; Fujimoto M; Inaoki M
J Dermatol; 2014 Jul; 41(7):664-5. PubMed ID: 24930560
[No Abstract] [Full Text] [Related]
35. Polymyxin-B Hemoperfusion as a Novel Treatment for Rapidly Progressive Interstitial Lung Disease in a Pediatric Patient Diagnosed With Anti-MDA5 Juvenile Dermatomyositis.
Mrosak J; Banasiak K; Edelheit B; Lapin C; Tory H; Collins MS
J Clin Rheumatol; 2021 Dec; 27(8S):S480-S484. PubMed ID: 31743264
[No Abstract] [Full Text] [Related]
36. Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis.
Gono T; Kawaguchi Y; Ozeki E; Ota Y; Satoh T; Kuwana M; Hara M; Yamanaka H
Mod Rheumatol; 2011 Apr; 21(2):223-7. PubMed ID: 21052763
[TBL] [Abstract][Full Text] [Related]
37. [Dermatomyositis associated with anti-MDA5 autoantibody].
Collado MV; Gargiulo MLÁ; Gómez R; Gómez G; Pérez N; Suarez L; Taratuto AL; Aruj P
Medicina (B Aires); 2018; 78(5):360-363. PubMed ID: 30285929
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil extracellular traps may contribute to interstitial lung disease associated with anti-MDA5 autoantibody positive dermatomyositis.
Peng Y; Zhang S; Zhao Y; Liu Y; Yan B
Clin Rheumatol; 2018 Jan; 37(1):107-115. PubMed ID: 28842784
[TBL] [Abstract][Full Text] [Related]
39. Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis.
Tsuji H; Nakashima R; Hosono Y; Imura Y; Yagita M; Yoshifuji H; Hirata S; Nojima T; Sugiyama E; Hatta K; Taguchi Y; Katayama M; Tanizawa K; Handa T; Uozumi R; Akizuki S; Murakami K; Hashimoto M; Tanaka M; Ohmura K; Mimori T
Arthritis Rheumatol; 2020 Mar; 72(3):488-498. PubMed ID: 31524333
[TBL] [Abstract][Full Text] [Related]
40. Anti-Ro 52 positive dermatomyositis presenting as rapidly progressive interstitial lung disease.
Conway R; O'Donnell R; Fahy R; Doran MF; Cunnane G; O'Shea FD
QJM; 2014 Jul; 107(7):593-4. PubMed ID: 24336848
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
